Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Stevens

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Causes & Control : CCC|February 11, 2025
Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patientsTheodore M Brasky, Shieun Lee, Bella McBride, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 18, 2024
Current cannabis use and pain management among US cancer patientsJessica L Krok-Schoen, Jesse J Plascak, Alison M Newton, et al.
Cancer Gene Therapy|March 23, 2021
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancerRodney P Rocconi, Erin E Stevens, Justin N Bottsford-Miller, et al.
The Lancet. Oncology|December 3, 2020
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trialRodney P Rocconi, Elizabeth A Grosen, Sharad A Ghamande, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Causes & Control : CCC|February 11, 2025
Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patientsTheodore M Brasky, Shieun Lee, Bella McBride, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 18, 2024
Current cannabis use and pain management among US cancer patientsJessica L Krok-Schoen, Jesse J Plascak, Alison M Newton, et al.
Cancer Gene Therapy|March 23, 2021
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancerRodney P Rocconi, Erin E Stevens, Justin N Bottsford-Miller, et al.
The Lancet. Oncology|December 3, 2020
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trialRodney P Rocconi, Elizabeth A Grosen, Sharad A Ghamande, et al.
Pageof 2